Bendle GM - Search Results

1

A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection.

Morris EC, Tsallios A, Bendle GM, Xue SA, Stauss HJ. Morris EC, et al. Among authors: bendle gm. Proc Natl Acad Sci U S A. 2005 May 31;102(22):7934-9. doi: 10.1073/pnas.0500357102. Epub 2005 May 20. Proc Natl Acad Sci U S A. 2005. PMID: 15908507 Free PMC article.

2

Prospects for immunotherapy of malignant disease.

Morris EC, Bendle GM, Stauss HJ. Morris EC, et al. Among authors: bendle gm. Clin Exp Immunol. 2003 Jan;131(1):1-7. doi: 10.1046/j.1365-2249.2003.02055.x. Clin Exp Immunol. 2003. PMID: 12519379 Free PMC article. Review.

3

Exploiting alloreactivity for tumour immunotherapy.

Stauss HJ, Xue S, Gillmore R, Gao L, Bendle G, Holler A, Downs AM, Morris E. Stauss HJ, et al. Vox Sang. 2004 Jul;87 Suppl 2:227-9. doi: 10.1111/j.1741-6892.2004.00493.x. Vox Sang. 2004. PMID: 15209922 Review. No abstract available.

4

Use of the allogeneic TCR repertoire to enhance anti-tumor immunity.

Xue S, Gillmore R, Gao L, Bendle G, Holler A, Downs AM, Tsallios A, Ramirez F, Ghani Y, Hart D, Alcock S, Tranter A, Morris E, Stauss HJ. Xue S, et al. J Biol Regul Homeost Agents. 2004 Apr-Jun;18(2):131-3. J Biol Regul Homeost Agents. 2004. PMID: 15471216 Review.

5

Induction of unresponsiveness limits tumor protection by adoptively transferred MDM2-specific cytotoxic T lymphocytes.

Bendle GM, Holler A, Pang LK, Hsu S, Krampera M, Simpson E, Stauss HJ. Bendle GM, et al. Cancer Res. 2004 Nov 1;64(21):8052-6. doi: 10.1158/0008-5472.CAN-04-0630. Cancer Res. 2004. PMID: 15520215

6

WT1-targeted immunotherapy of leukaemia.

Xue S, Gao L, Gillmore R, Bendle G, Holler A, Downs AM, Tsallios A, Ramirez F, Ghani Y, Hart D, Alcock S, Tranter A, Stauss HJ, Morris E. Xue S, et al. Blood Cells Mol Dis. 2004 Nov-Dec;33(3):288-90. doi: 10.1016/j.bcmd.2004.08.018. Blood Cells Mol Dis. 2004. PMID: 15528146

7

Broadly expressed tumour-associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy.

Bendle GM, Holler A, Downs AM, Xue SA, Stauss HJ. Bendle GM, et al. Expert Opin Biol Ther. 2005 Sep;5(9):1183-92. doi: 10.1517/14712598.5.9.1183. Expert Opin Biol Ther. 2005. PMID: 16120049 Review.

8

A study of T cell tolerance to the tumor-associated antigen MDM2: cytokines can restore antigen responsiveness, but not high avidity T cell function.

Bendle GM, Xue SA, Holler A, Stauss HJ. Bendle GM, et al. PLoS One. 2007 Apr 4;2(4):e353. doi: 10.1371/journal.pone.0000353. PLoS One. 2007. PMID: 17406677 Free PMC article.

9

CD8alpha/alpha homodimers fail to function as co-receptor for a CD8-dependent TCR.

McNicol AM, Bendle G, Holler A, Matjeka T, Dalton E, Rettig L, Zamoyska R, Uckert W, Xue SA, Stauss HJ. McNicol AM, et al. Eur J Immunol. 2007 Jun;37(6):1634-41. doi: 10.1002/eji.200636900. Eur J Immunol. 2007. PMID: 17506031 Free article.

10

Generation and characterization of transgenic mice expressing a T-cell receptor specific for the tumour-associated antigen MDM2.

Xue SA, Bendle GM, Holler A, Stauss HJ. Xue SA, et al. Among authors: bendle gm. Immunology. 2008 Jul;124(3):315-21. doi: 10.1111/j.1365-2567.2007.02793.x. Epub 2008 Jan 24. Immunology. 2008. PMID: 18217949 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters